The iconic success of Viagra, produced by copyright, undeniably reshaped the approach of erectile dysfunction , and fueled a massive boom in the pharmaceutical sector. However, now, investing in corporations reliant on mature blockbuster drugs like Viagra presents a complex landscape. Copycat competition is aggressive, significantly eroding revenue